Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases
dc.contributor.author | Thapa, P. | |
dc.contributor.author | Nikam, D. | |
dc.contributor.author | Das, T. | |
dc.contributor.author | Sonawane, G. | |
dc.contributor.author | Agarwal, J. P. | |
dc.contributor.author | Basu, Sandip | |
dc.date.accessioned | 2016-02-22T10:04:19Z | |
dc.date.available | 2016-02-22T10:04:19Z | |
dc.date.issued | 2015 | |
dc.description.division | RMC;RC&IG | en |
dc.format.extent | 5960 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Journal of Nuclear Medicine, 2015. Vol. 56 (10): pp. 1513-1519 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/12492 | |
dc.language.iso | en | en |
dc.subject | 177Lu-EDTMP | en |
dc.subject | 153Sm-EDTMP | en |
dc.subject | bone pain palliation | en |
dc.subject | bone alkaline phosphatase (BAP) | en |
dc.subject | skeletal metastases | en |
dc.title | Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases | en |
dc.type | Article | en |